iShares MSCI UK UCITS ETF (LON:CSUK)
London · Delayed Price · Currency is GBP · Price in GBX | Assets | 110.05M |
| Expense Ratio | 0.33% |
| PE Ratio | 18.00 |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Ex-Dividend Date | n/a |
| Payout Frequency | n/a |
| Payout Ratio | n/a |
| 1-Year Return | +23.68% |
| Volume | 64 |
| Open | 19,289 |
| Previous Close | 19,510 |
| Day's Range | 19,172 - 19,289 |
| 52-Week Low | 15,606 |
| 52-Week High | 20,250 |
| Beta | 0.91 |
| Holdings | 80 |
| Inception Date | Jan 12, 2010 |
About CSUK
iShares MSCI UK UCITS ETF is an exchange traded fund launched by BlackRock Asset Management Ireland Limited. The fund is managed by BlackRock Advisors (UK) Limited. It invests in the public equity markets of the United Kingdom. The fund seeks to invest in the stocks of companies operating across diversified sectors. It invests in the stocks of large-cap and mid-cap companies. The fund seeks to replicate the performance of the MSCI UK Index, by investing in the stocks of companies as per their weightings in the index. It was formerly known as CS ETF (IE) plc - CS ETF (IE) on MSCI UK. iShares MSCI UK UCITS ETF was formed on January 12, 2010 and is domiciled in Ireland.
Performance
CSUK had a total return of 23.68% in the past year, including dividends. Since the fund's inception, the average annual return has been 8.01%.
Top 10 Holdings
51.32% of assets| Name | Symbol | Weight |
|---|---|---|
| HSBC Holdings plc | HSBA | 9.62% |
| AstraZeneca PLC | AZN | 8.78% |
| Shell plc | SHEL | 7.51% |
| Rolls-Royce Holdings plc | RR | 4.35% |
| Unilever PLC | ULVR | 3.96% |
| British American Tobacco p.l.c. | BATS | 3.95% |
| Rio Tinto Group | RIO | 3.69% |
| BP p.l.c. | BP | 3.58% |
| GSK plc | GSK | 3.19% |
| National Grid plc | NG | 2.69% |